RCT | Treat-to-target dose reduction and withdrawal strategy of TNF inhibitors in psoriatic arthritis and axial spondyloarthritis.

Treat-to-target dose reduction and withdrawal strategy of TNF inhibitors in psoriatic arthritis and axial spondyloarthritis: a randomised controlled non-inferiority trial – Annals of Rheumatic Diseases (link to abstract – $ for full-text)

Commentary: TNF inhibitor tapered T2T strategy feasible in PsA and axSpA – medwireNews

Commentary on Twitter

Treat-to-target (#T2T) tapering strategy is an effective and safe alternative to a T2T full dose continuation strategy in patients with #psoriatic #arthritis and axial #spondyloarthritis with stable low disease activity using TNF inhibitorshttps://t.co/YhurbawiTm pic.twitter.com/1jj4zuYkPf

— ARD & RMD Open (@ARD_BMJ) June 18, 2022